ROYCE & ASSOCIATES LP - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$1,540,703
-44.6%
3,285,082
+30.0%
0.02%
-40.7%
Q2 2023$2,778,686
+17.5%
2,526,078
+27.1%
0.03%
+12.5%
Q1 2023$2,364,203
-10.6%
1,986,725
+11.9%
0.02%
-14.3%
Q4 2022$2,644,7501,775,0000.03%
Other shareholders
RECRO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders